Breast cancer is the most common cancer in women, with most cases occurring in patients with no identifiable family history or specific gene mutation
A state-of-the-art AI system capable of detecting a patient’s risk of developing breast cancer is expected to be launched in Israel in 2026 in a worldwide first, a Massachusetts Institute of Technology (MIT) computer science professor said on Wednesday.
The new technology and another for detecting lung cancer, which is simultaneously being tested in both Taiwan and Croatia, highlight the spread of artificial intelligence in the medical field, which experts say has the potential to revolutionize healthcare.
“By the nature of its organized and tech-savvy healthcare system, Israel has the potential to be at the forefront of the healthcare AI revolution,” MIT professor Regina Barzilay told JNS. “It will be a game-changer on many levels, and a very powerful tool to help early treatment.”
